Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model

Novel antimicrobials for effective treatment of uncomplicated gonorrhea are essential, and the first-in-class, oral spiropyrimidinetrione DNA gyrase B inhibitor zoliflodacin appears promising. Using our newly developed Hollow Fiber Infection Model (HFIM), the pharmacodynamics of zoliflodacin was exa...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Susanne Jacobsson, Daniel Golparian, Joakim Oxelbark, Francois Franceschi, David Brown, Arnold Louie, George Drusano, Magnus Unemo
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2022-04-01
Serie:	Frontiers in Pharmacology
Soggetti:	Neisseria gonorrhoeae hollow fiber infection model zoliflodacin antimicrobial treatment pharmacodynamics pharmacokinetics
Accesso online:	https://www.frontiersin.org/articles/10.3389/fphar.2022.874176/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!